Literature DB >> 9086669

Managed care and medical technology: implications for cost growth.

M Chernew1, A M Fendrick, R A Hirth.   

Abstract

Managed care health plans, particularly health maintenance organizations (HMOs), have been shown to reduce the level of health care spending. Their ability to constrain the long-term rate of health care cost growth is less certain and will depend largely on their ability to constrain the use of emerging medical technologies. Evidence from experience with one important medical technology, laparoscopic cholecystectomy, suggests no systematic difference between HMOs and the general population in the rate of growth in utilization following the introduction of new medical technology.

Mesh:

Year:  1997        PMID: 9086669     DOI: 10.1377/hlthaff.16.2.196

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  7 in total

1.  Does managed care fuel pharmaceutical industry growth?

Authors:  M D Murray; F W Deardorff
Journal:  Pharmacoeconomics       Date:  1998-10       Impact factor: 4.981

2.  Minimizing ports to improve laparoscopic cholecystectomy.

Authors:  P L Leggett; R Churchman-Winn; G Miller
Journal:  Surg Endosc       Date:  2000-01       Impact factor: 4.584

3.  Retrospective economic evaluation of the Hellenic Air Force Teleconsultation Project.

Authors:  G Labiris; C Tsitlakidis; D Niakas
Journal:  J Med Syst       Date:  2005-10       Impact factor: 4.460

4.  Geographic correlation between large-firm commercial spending and Medicare spending.

Authors:  Michael E Chernew; Lindsay M Sabik; Amitabh Chandra; Teresa B Gibson; Joseph P Newhouse
Journal:  Am J Manag Care       Date:  2010-02       Impact factor: 2.229

5.  In a survey, marked inconsistency in how oncologists judged value of high-cost cancer drugs in relation to gains in survival.

Authors:  Peter A Ubel; Scott R Berry; Eric Nadler; Chaim M Bell; Michael A Kozminski; Jennifer A Palmer; William K Evans; Elizabeth L Strevel; Peter J Neumann
Journal:  Health Aff (Millwood)       Date:  2012-04       Impact factor: 6.301

6.  Medical technology as a key driver of rising health expenditure: disentangling the relationship.

Authors:  Corinna Sorenson; Michael Drummond; Beena Bhuiyan Khan
Journal:  Clinicoecon Outcomes Res       Date:  2013-05-30

7.  Diffusion patterns of new anti-diabetic drugs into hospitals in Taiwan: the case of thiazolidinediones for diabetes.

Authors:  Yu-Wen Wen; Weng-Foung Huang; Yue-Chune Lee; Ken N Kuo; Chia-Rung Tsai; Yi-Wen Tsai
Journal:  BMC Health Serv Res       Date:  2011-01-31       Impact factor: 2.908

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.